Portfolio company
Redona Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Rezo Therapeutics
This biotechnology company develops drug discovery platforms and targeted therapies for oncology and other serious diseases, serving the pharmaceutical and healthcare industries.
Alphina Therapeutics
This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.
Ribon Therapeutics
This biotechnology company develops small molecule inhibitors targeting stress support pathways for patients with cancer and inflammatory diseases.
Eradivir
This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.
Ribometrix
The company develops small molecule therapeutics targeting RNA structures to treat human diseases for pharmaceutical partners and patients with cancer or neurodegenerative conditions.
Revona Bio
The company develops an RNA-targeted drug discovery platform to identify small-molecule compounds for pharmaceutical partners and biotechnology firms.
Apini Therapeutics
This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.
EXO Therapeutics
This biotechnology company develops small-molecule drugs targeting enzyme exosites for healthcare institutions and pharmaceutical partners to treat oncology and inflammatory diseases.
